Instrument Inactif

Communiqués New Age Farm Inc Canadian Securities Exchange

Actions

CA64157D1087

Recherche biotechnologique et médicale

Communiqués

09/09	Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting	NE
21/08	Noveris Health Sciences Announces Proposed Private Placement of Convertible Debentures for up to $500,000	NE
18/08	Noveris Health Sciences Receives USPTO Notice of Allowance, and Signs Work Order with API	NE
06/08	Noveris Health Sciences Inc. Unaware of Any Material Change	NE
30/07	Noveris Health Sciences Joins BioAlberta	NE
17/07	Noveris Health Sciences Joins the Biotechnology Innovation Organization (BIO)	AQ
14/07	Noveris Health Sciences Joins Life Sciences BC	AQ
29/06	Noveris Health Sciences Announces Upcoming AGM and Record Date, and receipt of CSE Notice	AQ
12/06	Noveris Health Sciences Announces Appointment Of Nathan Mison As Chair Of Advisory Board	AQ
08/06	Noveris Health Sciences Appoints Geoff Griffiths As Strategic Advisor To Support Commercialization And Growth Initiatives	AQ
05/06	Noveris Health Sciences Provides Corporate Update	AQ
29/04	Noveris Health Sciences Provides Corporate Update, and Announces Agreement for Acquisition of Stem Cell Distribution Business	AQ
23/04	Noveris Health Sciences Inc. Announces Signing Of Market Making Advisory Agreement With DS Market Solutions Inc.	AQ
20/04	Noveris Health Sciences Inc. Provides Clarifying News Release Regarding Life Offering And Other Disclosure	AQ
26/03	Noveris Provides Announces Trading Halt Order, And Clarification As To Article	AQ
17/03	Canadian Investment Regulatory Organization Trade Resumption - NVRS	AQ
16/03	Noveris Health Sciences Inc. Unaware Of Any Material Change	AQ
16/03	Canadian Investment Regulatory Organization Trading Halt - NVRS	AQ
14/03	Noveris Health Sciences Launches Investor Website and Engages Fairfax Partners Inc. for Investor Relations and Digital Marketing Services	AQ
12/03	Noveris Announces Life Offering	AQ
10/03	Noveris Announces Resignation Of CEO	AQ
07/03	Noveris Announces Conversion Of Debentures; Filing Of Early Warning Reports By JJK Holdings Ltd. And Joshua Bartch	AQ
27/02	JJK Holdings Ltd. Acquires $7,878,792 Convertible Debenture Of Noveris Health Sciences Inc.; Filing Of Early Warning Reports By JJK Holdings Ltd. And Pioneer Garage Limited	AQ
18/02	Noveris Provides Supplemental Disclosure Regarding Previously Announced Convertible Debenture Issuances	AQ